| Date Filed | Type | Description |
| 07/06/2023 |
4
| Requadt Scott (Former Chief Executive Officer) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 11,786 shares
@ $3.08, valued at
$36.3k
|
|
| 07/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2022 |
4
| Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Granted 80,000 shares
@ $0 |
|
| 08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/26/2021 |
4/A
| Requadt Scott (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2018 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 07/02/2018 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Converted 938,489 shares
@ $0
Converted 755,780 shares
@ $0
Converted 1,922,682 shares
@ $0
Bought 200,000 shares
@ $16, valued at
$3.2M
Converted 938,489 preferred shares
@ $0
Converted 755,780 preferred shares
@ $0
Converted 1,922,682 preferred shares
@ $0 |
|
| 06/27/2018 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Forty Seven, Inc. |
| 06/25/2018 |
4
| Requadt Scott (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Converted 2,283,434 shares
@ $0
Converted 678,891 shares
@ $0
Converted 9,435,150 preferred shares
@ $0
Converted 2,805,179 preferred shares
@ $0 |
|
| 06/20/2018 |
3
| Requadt Scott (Director) has filed a Form 3 on AVROBIO, Inc. |
| 06/18/2018 |
4
| Requadt Scott (Director) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Exercised 12,500 options to buy
@ $0 |
|
| 01/25/2018 |
4
| Requadt Scott (Director) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 75,000 options to buy
@ $4.19, valued at
$314.3k
|
|
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2017 |
4
| Requadt Scott (Director) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 12,500 options to buy
@ $3.79, valued at
$47.4k
|
|
| 04/04/2017 |
3
| Requadt Scott (Director) has filed a Form 3 on VBI Vaccines Inc/BC |